stockholders

Organovo’s Merger Deal with Tarveda Falls Through, for Now

It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…

Former CEO of Organovo Urges Stockholders Against Merger with Tarveda

Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…